Cell Culture Technology– category –
-
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Leading CDMOs Lonza, Samsung Biologics, Charles River Laboratories Spearhead Viral Vector Production, Legend Biotech Drives CAR-T Commercialization
GENE ONLINE|News & Opinion. Blog USA Overview Lonza, Samsung Biologics, and Charles River Laboratories are leading the complex viral vector manufacturing essential for scaling cell and gene therapies (CGTs), while Legend Biotech is drivi... -
Cell Culture Technology Weekly Report August 2, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 02, 2026 (PDF) — Download Weekly Report August 02, 2026 (PDF) — DownloadDownload 🎙 Podcast August 02, ... -
Scalable Automation in Adherent-Cell Cultures Boosts Yield and Quality: Corning’s HYPERStack and CellCube Systems Key to Efficiency
BioProcess International USA Overview Automation in scaling out adherent cell cultures significantly enhances consistency, proving especially effective where labor and bioprocessing expertise are limited. Automated culture platforms impr... -
Cell & Gene Therapy Manufacturing Faces Deepening Bottlenecks: AmplifyBio, Exothera Close; Thermo Fisher Cuts Viral Vector Jobs, but FDA Eases Regulations to Support Growth
Endpoints News Global Overview Despite cell and gene therapies becoming a commercial reality, manufacturing remains the primary bottleneck. The CDMO sector is struggling with overcapacity and underfunding, leading to closures like Amplif... -
Catalent Bolsters End-to-End CDMO Services for Autologous & Allogeneic Cell Therapies, Including iPSC Center of Excellence
Catalent USA Overview Catalent is enhancing its end-to-end CDMO manufacturing support and process development services for both autologous and allogeneic cell therapies, covering CAR-T, TCR, TIL, NK cells, and iPSC- and MSC-derived treat... -
Vivici Expands High-Purity Lactoferrin Production via Precision Fermentation, Delivering Animal-Free Nutritional Quality and Functionality
Vivici Netherlands Overview Vivici is advancing scalable production of lactoferrin, a rare bioactive protein, through precision fermentation technology. This approach enables access to high-purity lactoferrin without animal reliance, enh... -
All G Unveils Bovine-Free Lactoferrin in U.S. via Precision Fermentation, Establishing Multi-Ton Annual Production Capacity
foodnavigator-usa.com USA Overview All G has announced the launch of bovine-free lactoferrin in the U.S. market, produced using precision fermentation technology, with human-identical protein launch imminent. The company has partnered wi... -
ADM and The EVERY Company Partner to Scale Commercial Production of Precision-Fermented Egg Protein OvoPro, Transforming the Future of Food
flavorist.com USA Overview ADM and The EVERY Company announced a strategic partnership to accelerate commercial-scale production of OvoPro, EVERY's flagship precision-fermented egg protein. This collaboration combines EVERY's proprietary... -
Sartorius Unveils AI-Enabled Ambr 250 HT and Pionic Platform, Sustains Strong H1 2026 Business Growth and Profitability
boerse.de Germany Overview Sartorius Stedim Biotech has expanded its solution portfolio with the launch of the AI-enabled Ambr 250 HT Cell Therapies Vessel and the Pionic platform for intensified continuous bioprocessing. These innovatio...
